Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021

Descripción del Articulo

Objective: To determine antimicrobial resistance in secondary peritonitis in patients with chronic kidney disease (CKD) undergoing peritoneal dialysis at the Almanzor Aguinaga- Asenjo Hospital EsSalud-Lambayeque between 2019 and 2021. Material and methods: Descriptive and retrospective study, on 135...

Descripción completa

Detalles Bibliográficos
Autores: Díaz-Muñoz, Juan C., Serrano-Morales, Luis M., Pecsén-Monteza, José E.
Formato: artículo
Fecha de Publicación:2025
Institución:Colegio Médico del Perú
Repositorio:Acta Médica Peruana
Lenguaje:español
OAI Identifier:oai:amp.cmp.org.pe:article/2835
Enlace del recurso:https://amp.cmp.org.pe/index.php/AMP/article/view/2835
Nivel de acceso:acceso abierto
Materia:Peritoneal Dialysis
Peritonitis
Microbial Sensitivity Test
Anti-Bacterial Agents
Drug Resistance Microbial
Diálisis peritoneal
Pruebas de Sensibilidad Microbiana
Antibacterianos
Farmacorresistencia Microbiana
id REVCMP_7fdf25ce26616382409f489ba2f147eb
oai_identifier_str oai:amp.cmp.org.pe:article/2835
network_acronym_str REVCMP
network_name_str Acta Médica Peruana
repository_id_str .
spelling Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021Resistencia antibiótica de microorganismos enperitonitis secundaria a diálisis peritoneal en elHospital Almanzor Aguinaga Asenjo, EsSalud-Lambayeque 2019 – 2021Díaz-Muñoz, Juan C.Serrano-Morales, Luis M.Pecsén-Monteza, José E.Díaz-Muñoz, Juan C.Serrano-Morales, Luis M.Pecsén-Monteza, José E.Peritoneal DialysisPeritonitisMicrobial Sensitivity TestAnti-Bacterial AgentsDrug Resistance MicrobialDiálisis peritonealPeritonitisPruebas de Sensibilidad MicrobianaAntibacterianosFarmacorresistencia MicrobianaObjective: To determine antimicrobial resistance in secondary peritonitis in patients with chronic kidney disease (CKD) undergoing peritoneal dialysis at the Almanzor Aguinaga- Asenjo Hospital EsSalud-Lambayeque between 2019 and 2021. Material and methods: Descriptive and retrospective study, on 135 peritonitis episodes according to case records. Forty-seven episodes from 33 patients met inclusion criteria, and 88 episodes were excluded due to lack of reporting or bacterial isolation. Data was analyzed using the R studio 4.1.3 statistical package for Windows, expressing values as percentage and frequency. Results: More than half of patients (57.6%) were male, and median age was 54 years; 47.2% were diabetic and had high blood pressure. Oxacillin, vancomycin, gentamicin, and ciprofloxacin resistant coagulase-negative Staphylococcus were isolated (34%); cefazolin, ampicillin/sulbactam, and cotrimoxazole resistant Pseudomonas aeruginosa (21.3%); cotrimoxazole, ciprofloxacin, ceftriaxone, and cefepime resistant Escherichia coli (19.2%); and oxacillin and vancomycin resistant Staphylococcus aureus (10.6%) were also isolated. Conclusions: The most common antimicrobial-resistant microorganism is coagulase-negative Staphylococcus, found to be resistant to oxacillin, vancomycin, gentamicin, and ciprofloxacin.Objetivo: determinar la resistencia antibiótico-microbiana en peritonitis secundaria de pacientes con ERC en diálisis peritoneal del Hospital Almanzor Aguinaga Asenjo, EsSalud-Lambayeque, entre 2019 y 2021. Materiales y métodos: estudio descriptivo y retrospectivo, en 135 episodios de peritonitis según registro de casos; 47 episodios de 33 pacientes cumplieron criterios de inclusión y 88 episodios fueron excluidos por falta de reporte o aislamiento bacteriano. Los datos se analizaron con el paquete estadístico R Studio 4.1.3 para Windows, expresándolos en porcentajes y frecuencias. Resultados: el 57,6% fueron varones y la mediana de edad fue de 54 años; el 47,2% eran diabéticos e hipertensos; se aisló Staphylococcus coagulasa-negativo (34%), resistente a oxacilina, vancomicina, gentamicina y ciprofloxacino; Pseudomona aeruginosa (21,3%), resistente a cefazolina, ampicilina/sulbactam y cotrimoxazol; Escherichia coli (19,2%), resistentes a cotrimoxazol, ciprofloxacino, ceftriaxona y cefepime; y Staphylococcus aureus (10,6%), resistente a oxacilina y vancomicina. Conclusiones: el microorganismo más frecuente fue Staphylococcus coagulasa-negativo, resistente a oxacilina, vancomicina, gentamicina y ciprofloxacino.Colegio Médico del Perú2025-03-31info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdftext/xmlhttps://amp.cmp.org.pe/index.php/AMP/article/view/283510.35663/amp.2025.421.2835ACTA MEDICA PERUANA; Vol. 42 No. 1 (2025): January - March; 55-60ACTA MEDICA PERUANA; Vol. 42 Núm. 1 (2025): Enero – Marzo; 55-601728-59171018-8800reponame:Acta Médica Peruanainstname:Colegio Médico del Perúinstacron:CMPspahttps://amp.cmp.org.pe/index.php/AMP/article/view/2835/1957https://amp.cmp.org.pe/index.php/AMP/article/view/2835/1983Copyright (c) 2025 ACTA MEDICA PERUANAhttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessoai:amp.cmp.org.pe:article/28352025-11-08T19:15:30Z
dc.title.none.fl_str_mv Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021
Resistencia antibiótica de microorganismos enperitonitis secundaria a diálisis peritoneal en elHospital Almanzor Aguinaga Asenjo, EsSalud-Lambayeque 2019 – 2021
title Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021
spellingShingle Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021
Díaz-Muñoz, Juan C.
Peritoneal Dialysis
Peritonitis
Microbial Sensitivity Test
Anti-Bacterial Agents
Drug Resistance Microbial
Diálisis peritoneal
Peritonitis
Pruebas de Sensibilidad Microbiana
Antibacterianos
Farmacorresistencia Microbiana
title_short Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021
title_full Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021
title_fullStr Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021
title_full_unstemmed Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021
title_sort Antimicrobial resistance of microorganisms in peritonitissecondary to peritoneal dialysis at Almanzor Aguinaga -Asenjo Hospital, EsSalud - Lambayeque 2019 - 2021
dc.creator.none.fl_str_mv Díaz-Muñoz, Juan C.
Serrano-Morales, Luis M.
Pecsén-Monteza, José E.
Díaz-Muñoz, Juan C.
Serrano-Morales, Luis M.
Pecsén-Monteza, José E.
author Díaz-Muñoz, Juan C.
author_facet Díaz-Muñoz, Juan C.
Serrano-Morales, Luis M.
Pecsén-Monteza, José E.
author_role author
author2 Serrano-Morales, Luis M.
Pecsén-Monteza, José E.
author2_role author
author
dc.subject.none.fl_str_mv Peritoneal Dialysis
Peritonitis
Microbial Sensitivity Test
Anti-Bacterial Agents
Drug Resistance Microbial
Diálisis peritoneal
Peritonitis
Pruebas de Sensibilidad Microbiana
Antibacterianos
Farmacorresistencia Microbiana
topic Peritoneal Dialysis
Peritonitis
Microbial Sensitivity Test
Anti-Bacterial Agents
Drug Resistance Microbial
Diálisis peritoneal
Peritonitis
Pruebas de Sensibilidad Microbiana
Antibacterianos
Farmacorresistencia Microbiana
description Objective: To determine antimicrobial resistance in secondary peritonitis in patients with chronic kidney disease (CKD) undergoing peritoneal dialysis at the Almanzor Aguinaga- Asenjo Hospital EsSalud-Lambayeque between 2019 and 2021. Material and methods: Descriptive and retrospective study, on 135 peritonitis episodes according to case records. Forty-seven episodes from 33 patients met inclusion criteria, and 88 episodes were excluded due to lack of reporting or bacterial isolation. Data was analyzed using the R studio 4.1.3 statistical package for Windows, expressing values as percentage and frequency. Results: More than half of patients (57.6%) were male, and median age was 54 years; 47.2% were diabetic and had high blood pressure. Oxacillin, vancomycin, gentamicin, and ciprofloxacin resistant coagulase-negative Staphylococcus were isolated (34%); cefazolin, ampicillin/sulbactam, and cotrimoxazole resistant Pseudomonas aeruginosa (21.3%); cotrimoxazole, ciprofloxacin, ceftriaxone, and cefepime resistant Escherichia coli (19.2%); and oxacillin and vancomycin resistant Staphylococcus aureus (10.6%) were also isolated. Conclusions: The most common antimicrobial-resistant microorganism is coagulase-negative Staphylococcus, found to be resistant to oxacillin, vancomycin, gentamicin, and ciprofloxacin.
publishDate 2025
dc.date.none.fl_str_mv 2025-03-31
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2835
10.35663/amp.2025.421.2835
url https://amp.cmp.org.pe/index.php/AMP/article/view/2835
identifier_str_mv 10.35663/amp.2025.421.2835
dc.language.none.fl_str_mv spa
language spa
dc.relation.none.fl_str_mv https://amp.cmp.org.pe/index.php/AMP/article/view/2835/1957
https://amp.cmp.org.pe/index.php/AMP/article/view/2835/1983
dc.rights.none.fl_str_mv Copyright (c) 2025 ACTA MEDICA PERUANA
https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv Copyright (c) 2025 ACTA MEDICA PERUANA
https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
text/xml
dc.publisher.none.fl_str_mv Colegio Médico del Perú
publisher.none.fl_str_mv Colegio Médico del Perú
dc.source.none.fl_str_mv ACTA MEDICA PERUANA; Vol. 42 No. 1 (2025): January - March; 55-60
ACTA MEDICA PERUANA; Vol. 42 Núm. 1 (2025): Enero – Marzo; 55-60
1728-5917
1018-8800
reponame:Acta Médica Peruana
instname:Colegio Médico del Perú
instacron:CMP
instname_str Colegio Médico del Perú
instacron_str CMP
institution CMP
reponame_str Acta Médica Peruana
collection Acta Médica Peruana
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1849686670238023680
score 13.4082
Nota importante:
La información contenida en este registro es de entera responsabilidad de la institución que gestiona el repositorio institucional donde esta contenido este documento o set de datos. El CONCYTEC no se hace responsable por los contenidos (publicaciones y/o datos) accesibles a través del Repositorio Nacional Digital de Ciencia, Tecnología e Innovación de Acceso Abierto (ALICIA).